« Digital Biology group on LinkedIn | Main | Lilly's woes highlight the challenges of drug development »

Friday, July 23, 2010

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Shawn Yu

I read the book "The billion dollar molecule" couple years ago. It's about one of the first pharmaceutical company, Vertex Pharm, trying to use computer-aided drug design strategy in the early 90s. In the end, their approach failed miserably. However, a drug candidate from traditional screening, or aka "suck it and see" approach, ended up saving the company.

It's just amazing that 20 years later, the story really hasn't changed much.

Gordon Webster

Indeed Shawn - "The Billion Dollar Molecule" is a very interesting account of a pharmaceutical company's efforts to move towards designing drugs rather than discovering them and it perfectly highlights the problems mentioned in the article. Screening has enjoyed some success (like that described in the book), but taking a more long term view, the industry's heavy reliance upon such approaches does not seem to be paying off.

Jason Lyle

Nice overview of a major problem Gordon. As our industry evolves I hope one day we will not just be able to predict pharmacokinetics and metabolism but maybe even start to predict the likelyhood of serious adverse events. If the powers that be in major pharma are open to change then the future of drug development will be very exciting.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Bioinformatics, modeling and simulation, protein engineering. Amber Biology offers effective in silico strategies and expertise to accelerate commercial life science R&D programs.